Creating hemoglobin blood substitute with nitric oxide catalytic activity as antioxidants, anti-inflammation and immune-modulation therapeutic drugs for treatment of global unmet medical needs and healthcare including cancer, chemobrain, heart attack, trauma, shock, Alzheimer’s disease, dementia, blood transfusion, sickle cell disease and Covid pandemic are described.